Miller Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.5M Buy
120,316
+120,216
+120,216% +$15.8M 15.23% 3
2026
Q1
$13.9K Hold
100
0.01% 67
2025
Q4
$12.3K Hold
100
﹤0.01% 72
2025
Q3
$11.1K Hold
100
﹤0.01% 73
2025
Q2
$11.1K Hold
100
0.01% 64
2025
Q1
$11.2K Hold
100
0.01% 62
2024
Q4
$9.24K Hold
100
﹤0.01% 59
2024
Q3
$8.74K Hold
100
﹤0.01% 54
2024
Q2
$6.86K Hold
100
﹤0.01% 60
2024
Q1
$7.33K Hold
100
﹤0.01% 61
2023
Q4
$8.1K Hold
100
0.01% 54
2023
Q3
$7.49K Hold
100
0.01% 52
2023
Q2
$7.71K Buy
100
+15
+18% +$1.2K 0.01% 48
2023
Q1
$2K Sell
85
-115
-58% -$9.53K 0.01% 57
2022
Q4
$15K Buy
200
+100
+100% +$7.92K 0.01% 44
2022
Q3
$6K Hold
100
﹤0.01% 71
2022
Q2
$6K Hold
100
0.01% 63
2022
Q1
$6K Hold
100
﹤0.01% 68
2021
Q4
$7K Buy
+100
New +$6.89K ﹤0.01% 67

Other funds holding GILD

Miller Wealth Advisors's GILD Position: Q2 2026 in Review

Miller Wealth Advisors increased its Gilead Sciences (GILD) stake by 120,216% in Q2 2026, buying an estimated $15.8M and bringing the position to 120,316 shares worth $42.5M. The position accounts for 15.23% of the portfolio, ranked #3.

Miller Wealth Advisors first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Miller Wealth Advisors held 120,316 shares of Gilead Sciences worth $42.5M as of Q2 2026.
  • Miller Wealth Advisors bought 120,216 Gilead Sciences shares in Q2 2026, an estimated $15.8M.
  • Gilead Sciences made up 15.23% of Miller Wealth Advisors's portfolio in Q2 2026, its #3 holding.
  • Miller Wealth Advisors first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Miller Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.